Daito Pharmaceutical Co.,Ltd. (TSE:4577) announces a share repurchase program. Under the program, the company will repurchase up to 160,000 shares, representing 1.01% of its issued share capital (excluding treasury stock), for a total purchase price of ¥303.36 million. The shares will be repurchased at a price of ¥1,896 per share.

The purpose of the program is to improve capital efficiency, implement flexible capital policies in response to changes in the business environment, and enhance shareholder returns. As of December 31, 2023, the company has 15,850,770 issued shares (excluding treasury stock) and 7,670 treasury shares.